ANALYSIS OF COST AND OUTCOME THERAPY OF BLOOD TRANSFUSION ON ANEMIA TREATMENT FOR INPATIENT WITH CHRONIC RENAL FAILURE
Chronic Renal Failure (CRF) is a slow progressive loss of kidney function over a period of several years. One of its complications that determines the patient’s quality of life is anemia. Blood transfusion can be used to treat anemia in patient with CRF. The purpose of this study are to measure...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Gadjah Mada
2014-01-01
|
| Series: | Indonesian Journal of Pharmacy |
| Subjects: | |
| Online Access: | http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/19 |
| Summary: | Chronic Renal Failure (CRF) is a slow progressive loss of
kidney function over a period of several years. One of its
complications that determines the patient’s quality of life is anemia.
Blood transfusion can be used to treat anemia in patient with CRF.
The purpose of this study are to measure the average costs per
patient, assess the therapy outcomes, and determine the factors
that influence the cost of blood transfusion in anemia treatment for
patients with CRF in A, B, and C hospitals. This study was a
descriptive non-experimental research. Cost analysis was based on
the perspective of the hospital. Data were obtained retrospectively
from medical records and payment details of inpatient with CRF who
experienced anemia in A (tertiery hospital in Yogyakarta province),
B (tertiary hospital in Central Java province), and C (private hospital
in the province of Yogyakarta) hospitals. Data was analysed by
calculating the average costs per patient, while therapy outcome
was measured by calculating the percentages of patients who
achieved the target of hemoglobin level. Furthermore, the factors
that influenced the amount of the total cost were analysed using
Oneway ANOVA and Independent T-Test for data with normal
distribution and the Kruskal-Wallis and Mann-Whitney for data with
non-normal distribution. The results showed that the average costs
per patient for anemia treatment in patient with CRF who had blood
transfusion therapy were Rp 8,873,243.39±4,417,825.83 in A
hospital, Rp 5,249,464.97±4,283,655.41 in B hospital; and Rp
7,961,088.00±6,105,501.80 in C hospital. Most of the patients in A,
B, and C hospitals had achieved the target of hemoglobin level
(>7g/dL) with the percentages of 95.56%, 68.57% and 87.50%
respectively. The factors that mainly influenced the cost of anemia
treatment in CRF are length of hospitalization for A hospital, age,
gender, payment models, and length of hospitalization for B
hospital, whereas age and length of hospitalization for C hospital. |
|---|---|
| ISSN: | 2338-9427 2338-9486 |